Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Nutrition, physical activity, and lifestyle factors in prostate cancer prevention

Ballon-Landa, Eric; Parsons, J. Kellogg

doi: 10.1097/MOU.0000000000000460
PREVENTION IN UROLOGY: Edited by J. Kellogg Parsons and Maximilian Burger

Purpose of review To review current evidence for prostate cancer prevention with nutrition, physical activity, and lifestyle interventions and identify future research directions.

Recent findings Multiple preclinical and observational studies have observed that diet, exercise, and lifestyle interventions may play a role in mitigating disease progression, mortality, and overall disease burden for high-grade and fatal prostate cancer. Increased vegetable and fruit intakes, decreased red meat and saturated fat intakes, and increased exercise are potentially associated with decreased risk of incident disease and increased progression-free, prostate cancer-specific, and overall survival. Randomized controlled trials (RCTs) have demonstrated that selenium and vitamin C supplements are ineffective in preventing incident prostate cancer and that vitamin E supplements potentially increase incident prostate cancer risk. A large RCT of a high vegetable diet intervention among prostate cancer patients on active surveillance, the Men's Eating and Living study, will soon complete analysis. An RCT for an exercise intervention among men with metastatic castrate-resistant prostate cancer is currently accruing.

Summary Although preclinical and observational studies have identified potential benefits for high vegetable, low fat, low meat diets, and increased exercise, Level I evidence is limited. To inform clinical care, future research should focus on RCTs evaluating clinical effectiveness.

Department of Urology, University of California, San Diego, California, USA

Correspondence to J. Kellogg Parsons, MD, MHS, Department of Urology, University of California, San Diego, 9500 Gilman Drive #0987, La Jolla, CA 92093, USA. Tel: +1 858 822 7874; e-mail:

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.